These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 67712)

  • 41. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function.
    Schiffer CA; Aisner J; Schmukler M; Whitaker CL; Wolff JH
    Transfusion; 1975; 15(5):473-5. PubMed ID: 53920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic effects of 6% hydroxyethyl starch infusion in sevoflurane-anesthetized thoroughbred horses.
    Ohta M; Kurimoto S; Tokushige H; Kuroda T; Ishikawa Y
    J Vet Med Sci; 2013 Jul; 75(7):841-5. PubMed ID: 23411483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxyethyl starch-induced macroamylasemia.
    Köhler H; Kirch W; Horstmann HJ
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):428-31. PubMed ID: 72048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaphylactoid reactions due to hydroxyethyl starch infusion.
    Ring J; Seifert J; Messmer K; Brendel W
    Eur Surg Res; 1976; 8(5):389-99. PubMed ID: 62664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Morphological characteristics of the sequelae from the parenteral administration of solutions of hydroxyethyl starch].
    Prostakova TM; Glasko EN; Khokhlova MP; Polushina TV
    Arkh Patol; 1986; 48(7):43-7. PubMed ID: 2428336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy.
    Mishler JM
    Transfusion; 1975; 15(5):449-60. PubMed ID: 53917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixtures of whole blood and hydroxyethyl starch--hemoglobin polymers.
    Cerny LC; Cerny EL; Cerny ME; Baldwin JE; Gill B
    Crit Care Med; 1983 Sep; 11(9):739-43. PubMed ID: 6192972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of hydroxyethyl starch 200 kD on platelet function.
    Stögermüller B; Stark J; Willschke H; Felfernig M; Hoerauf K; Kozek-Langenecker SA
    Anesth Analg; 2000 Oct; 91(4):823-7. PubMed ID: 11004032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
    Asskali F; Förster H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Blood volume replacement and hemodilution with hydroxyethyl starch].
    Messmer K; Jesch F
    Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
    Ruttmann TG; James MF; Aronson I
    Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor.
    Huestis DW; White RF; Price MJ; Inman M
    Transfusion; 1975; 15(6):559-64. PubMed ID: 53922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G; McCombie N
    Transfusion; 1985; 25(5):417-9. PubMed ID: 2413591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An in vitro comparison of the effects of voluven (6% hydroxyethyl starch 130/0.4) and hespan (6% hydroxyethyl starch 670/0.75) on measures of blood coagulation in canine blood.
    Griego-Valles M; Buriko Y; Prittie JE; Fox PR
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):44-51. PubMed ID: 27712013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation].
    Khosropour R; Cerni C; Lackner F; Watzek C
    Anaesthesist; 1983 Jan; 32(1):25-7. PubMed ID: 6189413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.